Skip to main content
Top
Published in: Current Allergy and Asthma Reports 6/2010

01-11-2010

Molecular- and Flow Cytometry-based Diagnosis of Primary Immunodeficiency Disorders

Authors: Joao B. Oliveira, Thomas A. Fleisher

Published in: Current Allergy and Asthma Reports | Issue 6/2010

Login to get access

Abstract

Primary immunodeficiencies are an expanding group of genetic disorders resulting in recurrent and/or severe infections, autoimmunity, or autoinflammation. The laboratory plays a critical role in the diagnosis of these conditions given their frequently overlapping signs and symptoms. We discuss here advances in flow cytometry and molecular techniques applied to the study of primary immunodeficiencies.
Literature
1.
go back to reference Givan AL: Flow cytometry: an introduction. Methods Mol Biol 2004, 263:1–32.PubMed Givan AL: Flow cytometry: an introduction. Methods Mol Biol 2004, 263:1–32.PubMed
2.
go back to reference Loken MR, Brosnan JM, Bach BA, Ault KA: Establishing optimal lymphocyte gates for immunophenotyping by flow cytometry. Cytometry 1990, 11:453–459.CrossRefPubMed Loken MR, Brosnan JM, Bach BA, Ault KA: Establishing optimal lymphocyte gates for immunophenotyping by flow cytometry. Cytometry 1990, 11:453–459.CrossRefPubMed
3.
go back to reference Perfetto SP, Chattopadhyay PK, Roederer M. Seventeen-colour flow cytometry: unravelling the immune system. Nat Rev Immunol 2004, 4:648–655.CrossRefPubMed Perfetto SP, Chattopadhyay PK, Roederer M. Seventeen-colour flow cytometry: unravelling the immune system. Nat Rev Immunol 2004, 4:648–655.CrossRefPubMed
4.
go back to reference • Fleisher TA, Oliveira JB: Flow cytometry. In Clinical Immunology: Principles and Practice, edn 3. Edited by Rich RR, Shearer WT, Schroeder HW Jr, et al. Philadelphia, PA: Mosby Elsevier; 2008:1435–1446. This chapter provides a more in-depth discussion of the principles of flow cytometry as well as the applications of this technology. • Fleisher TA, Oliveira JB: Flow cytometry. In Clinical Immunology: Principles and Practice, edn 3. Edited by Rich RR, Shearer WT, Schroeder HW Jr, et al. Philadelphia, PA: Mosby Elsevier; 2008:1435–1446. This chapter provides a more in-depth discussion of the principles of flow cytometry as well as the applications of this technology.
5.
go back to reference Gratama JW, Kraan J, Keeney M, et al.: Validation of the single-platform ISHAGE method for CD34(+) hematopoietic stem and progenitor cell enumeration in an international multicenter study. Cytotherapy 2003, 5:55–65.CrossRefPubMed Gratama JW, Kraan J, Keeney M, et al.: Validation of the single-platform ISHAGE method for CD34(+) hematopoietic stem and progenitor cell enumeration in an international multicenter study. Cytotherapy 2003, 5:55–65.CrossRefPubMed
6.
go back to reference Oliveira JB, Notarangelo LD, Fleisher TA: Applications of flow cytometry for the study of primary immune deficiencies. Curr Opin Allergy Clin Immunol 2008, 8:499–509.CrossRefPubMed Oliveira JB, Notarangelo LD, Fleisher TA: Applications of flow cytometry for the study of primary immune deficiencies. Curr Opin Allergy Clin Immunol 2008, 8:499–509.CrossRefPubMed
7.
go back to reference Fleisher TA, Oliveira JB: Functional and molecular evaluation of lymphocytes. J Allergy Clin Immunol 2004, 114:227–234.CrossRefPubMed Fleisher TA, Oliveira JB: Functional and molecular evaluation of lymphocytes. J Allergy Clin Immunol 2004, 114:227–234.CrossRefPubMed
8.
9.
10.
go back to reference Yong PF, Chee R, Grimbacher B: Hypogammaglobulinaemia. Immunol Allergy Clin North Am 2008, 28:691–713.CrossRefPubMed Yong PF, Chee R, Grimbacher B: Hypogammaglobulinaemia. Immunol Allergy Clin North Am 2008, 28:691–713.CrossRefPubMed
11.
go back to reference Conley ME, Dobbs AK, Farmer DM, et al.: Primary B cell immunodeficiencies: comparisons and contrasts. Annu Rev Immunol 2009, 27:199–227.CrossRefPubMed Conley ME, Dobbs AK, Farmer DM, et al.: Primary B cell immunodeficiencies: comparisons and contrasts. Annu Rev Immunol 2009, 27:199–227.CrossRefPubMed
12.
go back to reference Futatani T, Watanabe C, Baba Y, et al.: Bruton’s tyrosine kinase is present in normal platelets and its absence identifies patients with X-linked agammaglobulinaemia and carrier females. Br J Haematol 2001, 114:141–149.CrossRefPubMed Futatani T, Watanabe C, Baba Y, et al.: Bruton’s tyrosine kinase is present in normal platelets and its absence identifies patients with X-linked agammaglobulinaemia and carrier females. Br J Haematol 2001, 114:141–149.CrossRefPubMed
13.
go back to reference Futatani T, Miyawaki T, Tsukada S, et al.: Deficient expression of Bruton’s tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection. Blood 1998, 91:595–602.PubMed Futatani T, Miyawaki T, Tsukada S, et al.: Deficient expression of Bruton’s tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection. Blood 1998, 91:595–602.PubMed
14.
go back to reference Wehr C, Kivioja T, Schmitt C, et al.: The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 2008, 111:77–85.CrossRefPubMed Wehr C, Kivioja T, Schmitt C, et al.: The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 2008, 111:77–85.CrossRefPubMed
15.
go back to reference Grimbacher B, Hutloff A, Schlesier M, et al.: Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 2003, 4:261–268.CrossRefPubMed Grimbacher B, Hutloff A, Schlesier M, et al.: Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 2003, 4:261–268.CrossRefPubMed
16.
go back to reference Bossaller L, Burger J, Draeger R, et al.: ICOS deficiency is associated with a severe reduction of CXCR5+ CD4 germinal center Th cells. J Immunol 2006, 177:4927–4932.PubMed Bossaller L, Burger J, Draeger R, et al.: ICOS deficiency is associated with a severe reduction of CXCR5+ CD4 germinal center Th cells. J Immunol 2006, 177:4927–4932.PubMed
17.
go back to reference Warnatz K, Salzer U, Rizzi M, et al.: B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans. Proc Natl Acad Sci U S A 2009, 106:13945–13950.CrossRefPubMed Warnatz K, Salzer U, Rizzi M, et al.: B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans. Proc Natl Acad Sci U S A 2009, 106:13945–13950.CrossRefPubMed
18.
go back to reference van Zelm MC, Reisli I, van der Burg M, et al.: An antibody-deficiency syndrome due to mutations in the CD19 gene. N Engl J Med 2006, 354:1901–1912.CrossRefPubMed van Zelm MC, Reisli I, van der Burg M, et al.: An antibody-deficiency syndrome due to mutations in the CD19 gene. N Engl J Med 2006, 354:1901–1912.CrossRefPubMed
19.
20.
go back to reference Lee WI, Torgerson TR, Schumacher MJ, et al.: Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome. Blood 2005, 105:1881–1890.CrossRefPubMed Lee WI, Torgerson TR, Schumacher MJ, et al.: Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome. Blood 2005, 105:1881–1890.CrossRefPubMed
21.
go back to reference Ferrari S, Giliani S, Insalaco A, et al.: Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc Natl Acad Sci U S A 2001, 98:12614–12619.CrossRefPubMed Ferrari S, Giliani S, Insalaco A, et al.: Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc Natl Acad Sci U S A 2001, 98:12614–12619.CrossRefPubMed
22.
go back to reference Puck JM: Severe combined immunodeficiency: new advances in diagnosis and treatment. Immunol Res 2007, 38:64–67.CrossRefPubMed Puck JM: Severe combined immunodeficiency: new advances in diagnosis and treatment. Immunol Res 2007, 38:64–67.CrossRefPubMed
23.
go back to reference Geha RS, Notarangelo LD, Casanova JL, et al.: Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol 2007, 120:776–794.CrossRefPubMed Geha RS, Notarangelo LD, Casanova JL, et al.: Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol 2007, 120:776–794.CrossRefPubMed
24.
25.
go back to reference Kawai S, Minegishi M, Ohashi Y, et al.: Flow cytometric determination of intracytoplasmic Wiskott-Aldrich syndrome protein in peripheral blood lymphocyte subpopulations. J Immunol Methods 2002, 260:195–205.CrossRefPubMed Kawai S, Minegishi M, Ohashi Y, et al.: Flow cytometric determination of intracytoplasmic Wiskott-Aldrich syndrome protein in peripheral blood lymphocyte subpopulations. J Immunol Methods 2002, 260:195–205.CrossRefPubMed
26.
go back to reference Bustamante J, Boisson-Dupuis S, Jouanguy E, et al.: Novel primary immunodeficiencies revealed by the investigation of paediatric infectious diseases. Curr Opin Immunol 2008, 20:39–48.CrossRefPubMed Bustamante J, Boisson-Dupuis S, Jouanguy E, et al.: Novel primary immunodeficiencies revealed by the investigation of paediatric infectious diseases. Curr Opin Immunol 2008, 20:39–48.CrossRefPubMed
27.
go back to reference Filipe-Santos O, Bustamante J, Chapgier A, et al.: Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features. Semin Immunol 2006, 18:347–361.CrossRefPubMed Filipe-Santos O, Bustamante J, Chapgier A, et al.: Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features. Semin Immunol 2006, 18:347–361.CrossRefPubMed
28.
go back to reference Fleisher TA, Dorman SE, Anderson JA, et al.: Detection of intracellular phosphorylated STAT-1 by flow cytometry. Clin Immunol 1999, 90:425–430.CrossRefPubMed Fleisher TA, Dorman SE, Anderson JA, et al.: Detection of intracellular phosphorylated STAT-1 by flow cytometry. Clin Immunol 1999, 90:425–430.CrossRefPubMed
29.
go back to reference Uzel G, Frucht DM, Fleisher TA, Holland SM: Detection of intracellular phosphorylated STAT-4 by flow cytometry. Clin Immunol 2001, 100:270–276.CrossRefPubMed Uzel G, Frucht DM, Fleisher TA, Holland SM: Detection of intracellular phosphorylated STAT-4 by flow cytometry. Clin Immunol 2001, 100:270–276.CrossRefPubMed
30.
go back to reference Nichols KE, Ma CS, Cannons JL, et al.: Molecular and cellular pathogenesis of X-linked lymphoproliferative disease. Immunol Rev 2005, 203:180–199.CrossRefPubMed Nichols KE, Ma CS, Cannons JL, et al.: Molecular and cellular pathogenesis of X-linked lymphoproliferative disease. Immunol Rev 2005, 203:180–199.CrossRefPubMed
31.
go back to reference Rigaud S, Fondaneche MC, Lambert N, et al.: XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature 2006, 444:110–114.CrossRefPubMed Rigaud S, Fondaneche MC, Lambert N, et al.: XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature 2006, 444:110–114.CrossRefPubMed
32.
go back to reference Zhu Q, Ochs H: Rapid flow cytometric screening for SAP and XIAP defects in patients with a phenotype of X-linked lymphoproliferative disease (XLP). Clin Immunol 2008, 127:s73.CrossRef Zhu Q, Ochs H: Rapid flow cytometric screening for SAP and XIAP defects in patients with a phenotype of X-linked lymphoproliferative disease (XLP). Clin Immunol 2008, 127:s73.CrossRef
33.
go back to reference Tabata Y, Villanueva J, Lee SM, et al.: Rapid detection of intracellular SH2D1A protein in cytotoxic lymphocytes from patients with X-linked lymphoproliferative disease and their family members. Blood 2005, 105:3066–3071.CrossRefPubMed Tabata Y, Villanueva J, Lee SM, et al.: Rapid detection of intracellular SH2D1A protein in cytotoxic lymphocytes from patients with X-linked lymphoproliferative disease and their family members. Blood 2005, 105:3066–3071.CrossRefPubMed
34.
go back to reference Filipovich AH: Hemophagocytic lymphohistiocytosis and other hemophagocytic disorders. Immunol Allergy Clin North Am 2008, 28:293–313, viii.CrossRefPubMed Filipovich AH: Hemophagocytic lymphohistiocytosis and other hemophagocytic disorders. Immunol Allergy Clin North Am 2008, 28:293–313, viii.CrossRefPubMed
35.
go back to reference Kogawa K, Lee SM, Villanueva J, et al.: Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members. Blood 2002, 99:61–66.CrossRefPubMed Kogawa K, Lee SM, Villanueva J, et al.: Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members. Blood 2002, 99:61–66.CrossRefPubMed
36.
go back to reference Marcenaro S, Gallo F, Martini S, et al.: Analysis of natural killer-cell function in familial hemophagocytic lymphohistiocytosis (FHL): defective CD107a surface expression heralds Munc13-4 defect and discriminates between genetic subtypes of the disease. Blood 2006, 108:2316–2323.CrossRefPubMed Marcenaro S, Gallo F, Martini S, et al.: Analysis of natural killer-cell function in familial hemophagocytic lymphohistiocytosis (FHL): defective CD107a surface expression heralds Munc13-4 defect and discriminates between genetic subtypes of the disease. Blood 2006, 108:2316–2323.CrossRefPubMed
37.
go back to reference Rosenzweig SD, Holland SM: Phagocyte immunodeficiencies and their infections. J Allergy Clin Immunol 2004, 113:620–626.CrossRefPubMed Rosenzweig SD, Holland SM: Phagocyte immunodeficiencies and their infections. J Allergy Clin Immunol 2004, 113:620–626.CrossRefPubMed
38.
go back to reference Jirapongsananuruk O, Malech HL, Kuhns DB, et al.: Diagnostic paradigm for evaluation of male patients with chronic granulomatous disease, based on the dihydrorhodamine 123 assay. J Allergy Clin Immunol 2003, 111:374–379.CrossRefPubMed Jirapongsananuruk O, Malech HL, Kuhns DB, et al.: Diagnostic paradigm for evaluation of male patients with chronic granulomatous disease, based on the dihydrorhodamine 123 assay. J Allergy Clin Immunol 2003, 111:374–379.CrossRefPubMed
39.
go back to reference Etzioni A: Defects in the leukocyte adhesion cascade. Clin Rev Allergy Immunol 2009, 38:54–60.CrossRef Etzioni A: Defects in the leukocyte adhesion cascade. Clin Rev Allergy Immunol 2009, 38:54–60.CrossRef
40.
go back to reference Torgerson TR, Ochs HD: Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: forkhead box protein 3 mutations and lack of regulatory T cells. J Allergy Clin Immunol 2007, 120:744–750.CrossRefPubMed Torgerson TR, Ochs HD: Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: forkhead box protein 3 mutations and lack of regulatory T cells. J Allergy Clin Immunol 2007, 120:744–750.CrossRefPubMed
41.
go back to reference Fleisher TA, Oliveira JB: Autoimmune lymphoproliferative syndrome. Isr Med Assoc J 2005, 7:758–761.PubMed Fleisher TA, Oliveira JB: Autoimmune lymphoproliferative syndrome. Isr Med Assoc J 2005, 7:758–761.PubMed
42.
go back to reference Bleesing JJ, Brown MR, Straus SE, et al.: Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome. Blood 2001, 98:2466–2473.CrossRefPubMed Bleesing JJ, Brown MR, Straus SE, et al.: Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome. Blood 2001, 98:2466–2473.CrossRefPubMed
43.
go back to reference Sanger F, Nicklen S, Coulson AR: DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A 1977, 74:5463–5467.CrossRefPubMed Sanger F, Nicklen S, Coulson AR: DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A 1977, 74:5463–5467.CrossRefPubMed
44.
go back to reference Hsu AP, Fleisher TA, Niemela JE: Mutation analysis in primary immunodeficiency diseases: case studies. Curr Opin Allergy Clin Immunol 2009, 9:517–524.CrossRefPubMed Hsu AP, Fleisher TA, Niemela JE: Mutation analysis in primary immunodeficiency diseases: case studies. Curr Opin Allergy Clin Immunol 2009, 9:517–524.CrossRefPubMed
45.
go back to reference Thusberg J, Vihinen M: Pathogenic or not? And if so, then how? Studying the effects of missense mutations using bioinformatics methods. Hum Mutat 2009, 30:703–714.CrossRefPubMed Thusberg J, Vihinen M: Pathogenic or not? And if so, then how? Studying the effects of missense mutations using bioinformatics methods. Hum Mutat 2009, 30:703–714.CrossRefPubMed
46.
47.
go back to reference Dion ML, Sekaly RP, Cheynier R: Estimating thymic function through quantification of T-cell receptor excision circles. Methods Mol Biol 2007, 380:197–213.CrossRefPubMed Dion ML, Sekaly RP, Cheynier R: Estimating thymic function through quantification of T-cell receptor excision circles. Methods Mol Biol 2007, 380:197–213.CrossRefPubMed
48.
go back to reference Puck JM: Population-based newborn screening for severe combined immunodeficiency: steps toward implementation. J Allergy Clin Immunol 2007, 120:760–768.CrossRefPubMed Puck JM: Population-based newborn screening for severe combined immunodeficiency: steps toward implementation. J Allergy Clin Immunol 2007, 120:760–768.CrossRefPubMed
49.
go back to reference Villa A, Notarangelo LD, Roifman CM: Omenn syndrome: inflammation in leaky severe combined immunodeficiency. J Allergy Clin Immunol 2008, 122:1082–1086.CrossRefPubMed Villa A, Notarangelo LD, Roifman CM: Omenn syndrome: inflammation in leaky severe combined immunodeficiency. J Allergy Clin Immunol 2008, 122:1082–1086.CrossRefPubMed
50.
go back to reference • Notarangelo LD, Fischer A, Geha RS, et al.: Primary immunodeficiencies: 2009 update. J Allergy Clin Immunol 2009, 124:1161–1178. This article provides in tabular form an outline of all currently recognized (at the time of publication) PIDs, including the specific molecular defect.CrossRefPubMed • Notarangelo LD, Fischer A, Geha RS, et al.: Primary immunodeficiencies: 2009 update. J Allergy Clin Immunol 2009, 124:1161–1178. This article provides in tabular form an outline of all currently recognized (at the time of publication) PIDs, including the specific molecular defect.CrossRefPubMed
Metadata
Title
Molecular- and Flow Cytometry-based Diagnosis of Primary Immunodeficiency Disorders
Authors
Joao B. Oliveira
Thomas A. Fleisher
Publication date
01-11-2010
Publisher
Current Science Inc.
Published in
Current Allergy and Asthma Reports / Issue 6/2010
Print ISSN: 1529-7322
Electronic ISSN: 1534-6315
DOI
https://doi.org/10.1007/s11882-010-0137-8

Other articles of this Issue 6/2010

Current Allergy and Asthma Reports 6/2010 Go to the issue